Avacta Group (AVCT)

 

Latest News

Notice of Results

RNS Number: 8219K Avacta Group PLC 26 September 2016 26 September 2016 Avacta Group plc ("Avacta" or "the Group" or "the Company") Notice of Results Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and research reagents, will announce its financial results for the year ended 31 July 2016 on Monday, 17 October 2016. ENDS Notes ...

Positive results from first preclinical studies

RNS Number: 5081K Avacta Group PLC 22 September 2016 22 September 2016 Avacta Group plc ("Avacta" or "the Group" or "the Company") Positive results from first preclinical in-vivo studies of Affimer therapeutics Affimer PD-L1 inhibitor significantly reduces tumour growth in mouse model Good pharmacokinetic properties observed Affimer molecules we...

Change of Adviser

RNS Number: 4822J Avacta Group PLC 12 September 2016 12 September 2016 Avacta Group plc ("Avacta" or "the Group" or "the Company") Change of Adviser Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and research reagents, is pleased to announce the appointment of finnCap Ltd as Nominated Adviser and Broker to the Company...

Avacta changes registered office

Avacta Group has changed the address of its registered office to Unit 20, Ash Way, Thorp Arch Estate, Wetherby, LS23 7F...

All News

DateHeadlineSource
26-09-16Notice of ResultsRNS
22-09-16Positive results from first preclinical studiesRNS
12-09-16Change of AdviserRNS
31-08-16Avacta changes registered office StockMarketWire
31-08-16Change of Registered OfficeRNS
16-08-16Avacta opens new facilities in Cambridge and WetherbyStockMarketWire
16-08-16New Facilities in Cambridge and WetherbyRNS
10-08-16Avacta gets grant funding for new diagnostic testsStockMarketWire
10-08-16Grant FundingRNS
03-08-16Avacta granted key Affimer patents in Europe and US StockMarketWire
03-08-16Key Affimer patents to be granted in Europe and USRNS
01-08-163 stocks set to soar after today’s news flow?Motley Fool
01-08-16Trading StatementRNS
19-07-16Holding(s) in CompanyRNS
19-07-16Hardman report: New Affimer opportunitiesRNS
14-07-16Collaboration with GlytheraRNS
08-07-16Director/PDMR ShareholdingRNS
22-06-16Avacta generates Affimer binders for Zika virus StockMarketWire
22-06-16Affimer Binders for Zika Virus DiagnosticsRNS
16-06-16Issue of EquityRNS
13-06-16Avacta collaborationStockMarketWire
13-06-16Collaboration with MologicRNS
29-04-16Director Deals - Avacta Group PLC (AVCT)StockMarketWire
29-04-16Director's DealingRNS
25-04-16Broker Forecast - Numis issues a broker note on Avacta Group PLCStockMarketWire
25-04-16Avacta revenues rise StockMarketWire
25-04-16Half-year ReportRNS
19-04-16Avacta achieves development milestone StockMarketWire
19-04-16Affimer Therapeutic Platform Development MilestoneRNS
07-04-16Director's DealingRNS
05-04-16Investor EveningRNS
24-03-16Should you buy shares worth less than 1p?Interactive Investor
15-03-16Issue of EquityRNS
07-03-16Avacta establishes scientific advisory boardStockMarketWire
07-03-16Avacta Establishes Scientific Advisory BoardRNS
25-02-16Holding(s) in CompanyRNS
24-02-16Grant Funding AwardedRNS
23-02-16Hardman & Co Issues Research ReportRNS
23-02-16Director's DealingRNS
17-02-16Avacta CEO and CFO granted options StockMarketWire

RSS feeds

  • Editorial news feed for LSE:AVCT Editorial
  • Regulatory news feed for LSE:AVCT Regulatory